This is the authors' abstract. We don't add key points for this paper.
Saccharomyces cerevisiae τ55, a subunit of the RNA polymerase III-specific general transcription factor TFIIIC, comprises an N-terminal histidine phosphatase domain (τ55-HPD) whose catalytic activity and cellular function is poorly understood. We solved the crystal structures of τ55-HPD and its closely related paralogue Huf and used in silico docking methods to identify phosphoserine- and phosphotyrosine-containing peptides as possible substrates that were subsequently validated using in vitro phosphatase assays. A comparative phosphoproteomic study identified additional phosphopeptides as possible targets that show the involvement of these two phosphatases in the regulation of a variety of cellular functions. Our results identify τ55-HPD and Huf as bona fide protein phosphatases, characterize their substrate specificities, and provide a small set of regulated phosphosite targets in vivo . Background: Subunit τ55 of TFIIIC contains a phosphatase domain of unknown function. Results: Crystal structures of the τ55 phosphatase domain and its paralogue Huf, in silico docking, in vitro candidate approaches, and in vivo phosphoproteomics identified phosphopeptides as substrates. Conclusion: τ55-HPD and Huf hydrolyze phosphopeptides in proteins of different cellular functions. Significance: Protein phosphatase activities of τ55 and Huf contribute to regulating metabolic networks.
No takes yet. Share an insight, caveat, or question.
Taylor et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: